RxDoctor Payments Data
★ My doctorsLook up a doctor →

Steven Pugh

Neurology · Spokane, WANPI 1952394272

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $109,061 of the $161,960 with a category attached, or 67.3%. 39 manufacturers reported payments, led by Biogen at 24.6% of the total. Reporting peaked in 2019 at $83,584 and has fallen 99.7% since, to $213 in 2023. Among neurology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$161,960in general payments, 2019–2025

Across 463 payments — averaging $349.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$40K
  • EMD Serono, Inc.$35K
  • Sanofi$26K
  • E.r. Squibb & Sons, L.L.C.$24K
  • Genentech USA, Inc.$17K
  • Teva Pharmaceuticals USA, Inc.$9K
  • plus $12K from 33 others
$465,738in research payments, 2019–2025

Across 16 payments — averaging $29,109 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$414K
  • Bristol Myers Squibb$24K
  • Sanofi$20K
  • Roche Products Limited$7K

What the payments were for

  • Consulting fees$26,38016%
  • Speaking & faculty fees$109,06167%
  • Travel & lodging$16,68410%
  • Food & beverage$9,8366%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen77$39,864
EMD Serono, Inc.69$35,021
Sanofi62$25,800
E.r. Squibb & Sons, L.L.C.22$23,700
Genentech USA, Inc.29$16,839
Teva Pharmaceuticals USA, Inc.12$9,178
Bristol Myers Squibb22$7,690
Novartis27$1,029
AbbVie(2 entities)25$504
Amgen(2 entities)14$245
Boston Scientific12$219
Acorda Therapeutics, Inc8$150
Impel Pharmaceuticals Inc.7$144
Argenx US, Inc.4$129
AstraZeneca5$114
Neurocrine Biosciences, Inc.6$107
Upsher-smith Laboratories LLC6$104
CSL Behring5$101
Lilly USA, LLC4$99
Medtronic(2 entities)5$97
Acadia Pharmaceuticals Inc5$93
Amneal Pharmaceuticals LLC5$87
Merz North America, Inc.3$84
Lundbeck LLC3$59
ANI Pharmaceuticals, Inc.3$59
Banner Life Sciences, LLC3$56
Genentech, Inc.1$52
Merz Pharmaceuticals, LLC2$47
Ipsen Biopharmaceuticals, Inc3$46
GE HealthCare2$41
Kyowa Kirin, Inc.2$40
Johnson & Johnson2$39
Biohaven Pharmaceuticals, Inc.2$34
Xeris Pharmaceuticals, Inc.1$21
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Avanir Pharmaceuticals, Inc.1$15
Strongbridge US Inc.1$13
Biohaven Pharmaceutical Holding Company Ltd.1$12
Kedrion Biopharma, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$161,960 in reported general payments places this provider in the 95th percentile of 418 neurology providers in Washington.

See all neurology providers in Washington →

Other neurology in Spokane

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →